NRx Pharmaceuticals
Tracked across 2 events · 17 articles · First seen Apr 15, 2026 · Last active Jun 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: NRx Pharmaceuticals incorporated NRx Defense Systems, Inc. as a new R&D subsidiary to develop neuroplastic treatments for military and first responders, which could open new revenue streams and enhance its market position.
Apr 15, 2026 · 7 articles
Business
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of 5,714,286 shares of its common stock at $3.50 per share. The offering is expected to generate approximately $20.0 million in…
Impact: NRx Pharmaceuticals announced the pricing of a public offering of its common stock, aiming to raise approximately $20.0 million for working capital and general corporate purposes to support its growth. This offering will dilute existing shareholders but provide capital for the company's operations and development of its therapeutics.
Jun 02, 2026 · 10 articles
100
NRx Pharmaceuticals announced pricing of offeringNRx Pharmaceuticals Prices...
90
NRx Pharmaceuticals intends to use proceedsNRx Pharmaceuticals Prices...
70
BTIG acted as lead manager NRx PharmaceuticalsNRx Pharmaceuticals Prices...
60
Lucid Capital Markets acted as joint manager NRx PharmaceuticalsNRx Pharmaceuticals Prices...
NEWSDESK
Track NRx Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard